DrugPatentWatch Database Preview
Drugs in MeSH Category Sodium Channel Blockers
Email this page to a colleague
» See Plans and Pricing| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 211707-002 | May 28, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Teva | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | TABLET;ORAL | 074895-001 | Apr 16, 1999 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Ben Venue | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | INJECTABLE;INJECTION | 076088-001 | Oct 15, 2002 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Sun Pharm | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 211707-001 | May 28, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Murty Pharms | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | TABLET;ORAL | 077069-001 | Apr 8, 2005 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Aurobindo Pharma Ltd | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | INJECTABLE;INJECTION | 204550-001 | Oct 25, 2017 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Micro Labs | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 211745-001 | Feb 27, 2020 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
